Stay updated on iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Sign up to get notified when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.

Latest updates to the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA banner announces upcoming NIH website changes and says agencies are transitioning from “Artificial Intelligence” to “Super Intelligence” terminology. The study page continues to show a 403 Forbidden error.SummaryDifference1%

- Check18 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedRemoved the 403 Forbidden error page content and its HTML markup that displayed when access to the study page was blocked.SummaryDifference0.5%

- Check46 days agoChange DetectedThe page now returns a 403 Forbidden error, replacing the study details with an error page. This indicates access restrictions that prevent viewing the trial information on this URL.SummaryDifference20%

Stay in the know with updates to iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iTRAP: ADI-PEG 20 Combo in Arginine-Req Tumours Clinical Trial page.